Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer

NCT01037790 is registered in ClinicalTrials.gov with Abramson Cancer Center at Penn Medicine as lead sponsor.

NCT NCT01037790
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01037790 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer
Lead sponsor
Abramson Cancer Center at Penn Medicine
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2009
Completion date
October 31, 2019
Enrollment
304 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma of the colon, adenocarcinoma of the rectum, adult central nervous system germ cell tumor, adult solid tumor, adult teratoma, benign teratoma, estrogen receptor-negative breast cancer, estrogen receptor-positive breast cancer, familial testicular germ cell tumor, her2-negative breast cancer, her2-positive breast cancer, male breast cancer, ovarian immature teratoma, ovarian mature teratoma, ovarian monodermal and highly specialized teratoma, progesterone receptor-negative breast cancer, progesterone receptor-positive breast cancer, recurrent breast cancer, recurrent colon cancer, recurrent extragonadal germ cell tumor, recurrent extragonadal non-seminomatous germ cell tumor, recurrent extragonadal seminoma, recurrent malignant testicular germ cell tumor, recurrent melanoma, recurrent ovarian germ cell tumor, recurrent rectal cancer, stage iii extragonadal non-seminomatous germ cell tumor, stage iii extragonadal seminoma, stage iii malignant testicular germ cell tumor, stage iii ovarian germ cell tumor, stage iv breast cancer, stage iv colon cancer, stage iv extragonadal non-seminomatous germ cell tumor, stage iv extragonadal seminoma, stage iv melanoma, stage iv ovarian germ cell tumor, stage iv rectal cancer, testicular immature teratoma, testicular mature teratoma